| Mechanisms of diabetic complications JM Forbes, ME Cooper Physiological reviews 93 (1), 137-188, 2013 | 3327 | 2013 |
| Oxidative stress as a major culprit in kidney disease in diabetes JM Forbes, MT Coughlan, ME Cooper Diabetes 57 (6), 1446-1454, 2008 | 1538 | 2008 |
| A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes R Candido, JM Forbes, MC Thomas, V Thallas, RG Dean, WC Burns, ... Circulation research 92 (7), 785-792, 2003 | 658 | 2003 |
| Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) MD Oldfield, LA Bach, JM Forbes, D Nikolic-Paterson, A McRobert, ... The Journal of clinical investigation 108 (12), 1853-1863, 2001 | 618 | 2001 |
| Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy A Bierhaus, T Fleming, S Stoyanov, A Leffler, A Babes, C Neacsu, ... Nature medicine 18 (6), 926-933, 2012 | 576 | 2012 |
| Brain atrophy in type 2 diabetes: regional distribution and influence on cognition C Moran, TG Phan, J Chen, L Blizzard, R Beare, A Venn, G Münch, ... Diabetes care 36 (12), 4036-4042, 2013 | 573 | 2013 |
| RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes MT Coughlan, DR Thorburn, SA Penfold, A Laskowski, BE Harcourt, ... Journal of the American Society of Nephrology 20 (4), 742-752, 2009 | 527 | 2009 |
| Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy C Tikellis, CI Johnston, JM Forbes, WC Burns, LM Burrell, J Risvanis, ... Hypertension 41 (3), 392-397, 2003 | 505 | 2003 |
| Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes A Soro-Paavonen, AMD Watson, J Li, K Paavonen, A Koitka, AC Calkin, ... Diabetes 57 (9), 2461-2469, 2008 | 503 | 2008 |
| Mitochondrial dysfunction in diabetic kidney disease JM Forbes, DR Thorburn Nature Reviews Nephrology 14 (5), 291-312, 2018 | 499 | 2018 |
| AGE, RAGE, and ROS in diabetic nephropathy ALY Tan, JM Forbes, ME Cooper Seminars in nephrology 27 (2), 130-143, 2007 | 497 | 2007 |
| High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus BG Drew, SJ Duffy, MF Formosa, AK Natoli, DC Henstridge, SA Penfold, ... Circulation 119 (15), 2103-2111, 2009 | 489 | 2009 |
| Role of advanced glycation end products in diabetic nephropathy JM Forbes, ME Cooper, MD Oldfield, MC Thomas Journal of the American Society of Nephrology 14 (suppl_3), S254-S258, 2003 | 461 | 2003 |
| Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis JM Forbes, LTL Yee, V Thallas, M Lassila, R Candido, ... Diabetes 53 (7), 1813-1823, 2004 | 427 | 2004 |
| Inhibition of NADPH oxidase prevents advanced glycation end product–mediated damage in diabetic nephropathy through a protein kinase C-α–dependent pathway V Thallas-Bonke, SR Thorpe, MT Coughlan, K Fukami, FYT Yap, ... Diabetes 57 (2), 460-469, 2008 | 415 | 2008 |
| Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy JM Forbes, ME Cooper, V Thallas, WC Burns, MC Thomas, GC Brammar, ... Diabetes 51 (11), 3274-3282, 2002 | 407 | 2002 |
| Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial M Rossi, DW Johnson, M Morrison, EM Pascoe, JS Coombes, JM Forbes, ... Clinical Journal of the American Society of Nephrology 11 (2), 223-231, 2016 | 403 | 2016 |
| The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes JM Forbes, V Thallas, MC Thomas, HW Founds, WC Burns, G Jerums, ... The FASEB Journal 17 (12), 1762-1764, 2003 | 350 | 2003 |
| Effects of SGLT2 inhibition in human kidney proximal tubular cells—renoprotection in diabetic nephropathy? U Panchapakesan, K Pegg, S Gross, MG Komala, H Mudaliar, J Forbes, ... PloS one 8 (2), e54442, 2013 | 348 | 2013 |
| Connective tissue growth factor plays an important role in advanced glycation end product–induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal … WC Burns, SM Twigg, JM Forbes, J Pete, C Tikellis, V Thallas-Bonke, ... Journal of the American Society of Nephrology 17 (9), 2484-2494, 2006 | 346 | 2006 |
Mark CooperDepartment of Diabetes, Monash UniversityVerificeret mail på monash.edu
